flucytosine has been researched along with Carcinoma, Renal Cell in 1 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirakawa, T | 1 |
| Gardner, TA | 1 |
| Ko, SC | 1 |
| Bander, N | 1 |
| Woo, S | 1 |
| Gotoh, A | 1 |
| Kamidono, S | 1 |
| Chung, LW | 1 |
| Kao, C | 1 |
1 other study available for flucytosine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model.
Topics: Acyclovir; Adenoviridae; Antimetabolites; Carcinoma, Renal Cell; Cytosine Deaminase; Flucytosine; Ge | 1999 |